Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding Study of S62798 in Intermediate-high Risk Acute Pulmonary Embolism
2019-003514-14Phase 2Terminated
- Sponsor
- Servier
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of S62798 in pulmonary embolism (PE) (4 arms), sponsored by Servier. Primary endpoint: Right / left ventricular end-diastolic diameter (RV/LV EDD). Started Mar 2020; status: terminated.
02
Drugs
S62798
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on 2019-003514-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003514-14.